Clinical trial · Observational
Robotic Laparoscopic Radical Prostatectomy
NCT00292019CI-TRIAL-00029299completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a pilot study to evaluate the role of RALRP in the management of localized prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopic | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Robotic prostatectomy
- description
- Patients who are eligible for a radical prostatectomy will have their surgery conducted with the aid of surgical robotics.
- interventionNames
- Procedure: Laparoscopic
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Informed Consent 2. Locally confined, stage T1a, T2a or T2b prostate cancer 3. Aged 40-65 and judged by the study doctor to be a suitable candidate for a radical prostatectomy. 4. Serum prostate specific antigen equal to or less than 10mg/ml 5. Histologically confirmed adenocarcinoma of the prostate 6. Gleason score equal to or less than 7 7. Life expectancy of greater than 10 years. 8. Prostate size on TRUS measurement less than 40 grams Exclusion Criteria: 1. Patients who have undergone prior hormone therapy. 2. Patients with a previous transurethral resectioning of the prostate (TURP) 3. History of other cancers other than basal cell carcinoma. 4. Patients with any prior abdominal surgery. 5. Any condition, or history of illness or surgery than, in the opinion of the investigator, might confound the results of the study or pose additional risk to the patient (eg significant cardiovascular conditions) 6. Patients with a large median lobe of the prostate. - Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.